Experts disagree on whether prostate cancer with a Gleason score of 6 (GS6) should be re-labeled as non-cancerous. Writing in a commentary in the Journal of Clinical Oncology, Scott Eggener, MD, and ...
There is disagreement in the medical community about a proposal to relabel prostate cancer Gleason score 6 (GS6) as non-cancerous, as detailed by recent commentaries in the Journal of Clinical ...
Biden's cancer is characterized as having a Gleason score of 9. Here's what to know about the system for describing prostate cancer and what it means.
Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP inhibitor eligibility now requires genetic testing at the hormone-sensitive ...
About 1 in 8 American men will get a prostate cancer diagnosis, researchers say. What to know about the disease following ...
The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer.
The Prolaris test on diagnostic biopsy for localized prostate cancer prognosis across risk groups and management: An individual participant data meta-analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results